Manufacturers Life Insurance Company, The Theseus Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$2.66 - $10.04 $21,625 - $81,625	-8,130 Reduced 9.25%	79,751 $214,000
Q2 2023 Aug 11, 2023	BUY	$7.28 - $11.82 $231,598 - $376,029	31,813 Added 56.74%	87,881 $819,000
Q1 2023 May 15, 2023	BUY	$5.21 - $14.05 $123,388 - $332,746	23,683 Added 42.24%	79,751 $708,000
Q4 2022 Aug 11, 2023	BUY	$4.69 - $8.36 $867 - $1,546	185 Added 0.33%	56,068 $279,000
Q4 2022 Feb 13, 2023	BUY	$4.69 - $8.36 $867 - $1,546	185 Added 0.33%	56,068 $279,000
Q2 2022 Aug 11, 2023	SELL	$5.04 - $14.05 $20,361 - $56,762	-4,040 Reduced 6.74%	55,883 $309,000
Q2 2022 Aug 15, 2022	SELL	$5.04 - $14.05 $20,361 - $56,762	-4,040 Reduced 6.74%	55,883 $291,000
Q1 2022 Aug 11, 2023	SELL	$8.75 - $14.51 $173,495 - $287,704	-19,828 Reduced 24.86%	59,923 $690,000
Q1 2022 May 20, 2022	BUY	$8.75 - $14.51 $524,326 - $869,482	59,923 New	59,923 $701,000

1.03M

Ticker THRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,713,400
Description
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company also ...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.